α-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate

British Journal of Cancer

Volumn 102, Issue 8, 2010, Pages 1224-1234

  Tomasetti, M ^a   Strafella, E ^a   Staffolani, S ^a   Santarelli, L ^a   Neuzil, J ^b,c   Guerrieri, R ^d  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b GRIFFITH UNIVERSITY   (Australia)

^c INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

tocopheryl succinate; Ascorbic acid; Prostate cancer; Synergism; Vitamin E; Vitamin K3

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; ASCORBIC ACID; CASPASE; CYTOCHROME C; MENADIONE; PROTEINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CONTROLLED STUDY; CYTOSKELETON; DNA DAMAGE; DRUG RESPONSE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LETHAL DOSE; LIPID PEROXIDATION; PRIORITY JOURNAL; PROSTATE CANCER;

ALPHA-TOCOPHEROL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; ASCORBIC ACID; CELL DEATH; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; FIBROBLASTS; HUMANS; LYSOSOMES; MALE; MITOCHONDRIA; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; VITAMIN K 3;

EID: 77950865121     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605617     Document Type: Article

References (56)

1. Beauchamp MC, Knafo A, Yasmeen A, Carboni JM, Gottardis MM, Pollak MN, Gotlieb WH (2009) BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide. Gynecol Oncol 155(2): 193-198
2. Beck R, Verrax J, Dejeans N, Taper H, Calderon PB (2009) Menadione reduction by pharmacological doses of ascorbate induces an oxidative stress that kills breast cancer cells. Int J Toxicol 28: 33-42
3. Boersma AWM, Nooter K, Oostrum RG, Stoter G (1996) Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in Chinese Hamster ovary cell cultures treated with cisplatin. Cytometry 24: 123-130 (Pubitemid 26193936)
4. Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D, Ojcius DM, Jäättelä M, Kroemer G (2003) Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 197: 1323-1934 (Pubitemid 36617779)
5. Buc-Calderon P, Praet M, Ruysschaert JM, Roberfroid M (1989) Increasing therapeutic effect and reducing toxicity of doxorubicin by N-acyl dehydroalanines. Eur J Cancer Clin Oncol 25: 679-685 (Pubitemid 19096437)
6. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47: 943-946 (Pubitemid 17027906)
7. Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR, Levine M (2007) Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA 104: 8749-8754 (Pubitemid 47175383)
8. Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, Levine M (2005) Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA 102: 13604-13609 (Pubitemid 41420895)
9. D'Alessio M, De Nicola M, Coppola S, Gualandi G, Pugliese L, Cerella C, Cristofanon S, Civitareale P, Ciriolo MR, Bergamaschi A, Magrini A, Ghibelli L (2005) Oxidative Bax dimerization promotes its translocation to mitochondria independently of apoptosis. FASEB J 19: 1504-1506 (Pubitemid 41279012)
10. De Loecker W, Janssens J, Bonte J, Taper HS (1993) Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. II. Synergism with combined chemotherapy action. Anticancer Res 13: 103-106 (Pubitemid 23118203)
11. Dong LF, Freeman R, Liu J, Zobalova R, Marin-Hernandez A, Stantic M, Rohlena J, Valis K, Rodriguez-Enriquez S, Butcher B, Goodwin J, Brunk UT, Witting PK, Moreno-Sanchez R, Scheffler IE, Ralph SJ, Neuzil J (2009) Suppression of tumor growth in vivo by the mitocan alphatocopheryl succinate requires respiratory complex II. Clin Cancer Res 15: 1593-1600
12. Dong LF, Low P, Dyason J, Wang XF, Prochazka L, Witting PK, Freeman R, Swettenham E, Valis K, Liu J, Zobalova R, Turanek J, Spitz DR, Domann FE, Scheffler IE, Ralph SJ, Neuzil J (2008) α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 27: 4324-4335 (Pubitemid 352010000)
13. Eichhorn ME, Ischenko I, Luedemann S, Strieth S, Papyan A, Werner A, Bohnenkamp H, Guenzi E, Preissler G, Michaelis U, Jauch KW, Bruns CJ, Dellian M (2010) Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer. Int J Cancer 126(5): 1235-1245
14. Fantin VR, Leder P (2006) Mitochondriotoxic compounds for cancer therapy. Oncogene 25: 4787-4797 (Pubitemid 44187626)
15. Gogvadze V, Orrenius S, Zhivotovsky B (2008) Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 18: 165-173
16. Gilloteaux J, Jamison JM, Arnold D, Ervin E, Eckroat L, Docherty JJ, Neal D, Summers JL (1998) Cancer cell necrosis by autoschizis: synergism of antitumor activity of vitamin C: vitamin K3 on human bladder carcinoma T24 cells. Scanning 20: 564-575 (Pubitemid 29031300)
17. Gilloteaux J, Jamison JM, Arnold D, Taper HS, Summers JL (2001) Ultrastructural aspects of autoschizis: a new cancer cell death induced by the synergistic action of ascorbate/menadione on human bladder carcinoma cells. Ultrastruct Pathol 25: 183-192 (Pubitemid 32607291)
18. Gilloteaux J, Jamison JM, Neal DR, Summers JL (2005) Cell death by autoschizis in TRAMP prostate carcinoma cells as a result of treatment by ascorbate: menadione combination. Ultrastruct Pathol 29: 221-235 (Pubitemid 40993748)
19. Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4: 682-690
20. Jamison JM, Gilloteaux J, Venugopal M, Koch JA, Sowick C, Shah R, Summers JL (1996) Flow cytometric and ultrastructural aspects of the synergistic antitumor activity of vitamin C-vitamin K3 combinations against human prostatic carcinoma cells. Tissue Cell 28: 687-701 (Pubitemid 27011032)
21. Jamison JM, Gilloteaux J, Taper HS, Buc Calderon P, Perlaky L, Thiry M (2005) The in vitro and in vivo antitumor activity of vitamin C:K3 combinations against prostate cancer. In: Trends in Prostate Cancer Research, Lucas JL (ed) 189-236. Nova Science Publishers: Hauppauge, NY
22. Kassouf W, Dinney CP, Brown G, McConkey DJ, Diehl AJ, Bar-Eli M, Adam L (2005) Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells. Cancer Res 65: 10524-10535 (Pubitemid 41748146)
23. Keith CT, Borisy AA, Stockwell BR (2005) Multicomponent therapeutics for networked systems. Nat Rev Drug Discov 4: 71-78
24. Kitano H (2007) Robustness-based approach to systems-oriented drug design. Nat Rev Drug Discov 6: 202-210 (Pubitemid 46344624)
25. Koch N, van Driel IR, Gleeson PA (2000) Hijacking a chaperone: manipulation of the MHC class II presentation pathway. Immunol Today 21: 546-550
26. Lehár J, Krueger AS, Avery W, Heilbut AM, Johansen LM, Price ER, Rickles RJ, Short III GF, Staunton JE, Jin X, Lee MS, Zimmermann GR, Borisy AA (2009) Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol 27: 659-666
27. Lu W, Dong Z, Donawho C, Fidler IJ (2002) Specific immunotherapy against occult cancer metastases. Int J Cancer 100: 480-485 (Pubitemid 34721636)
28. Mannick JB, Schonhoff C, Papeta N, Ghafourifar P, Szibor M, Fang K, Gaston B (2001) S-nitrosylation of mitochondrial caspases. J Cell Biol 154: 1111-1116 (Pubitemid 34286189)
29. Neuzil J, Dong LF, Ramanathapuram L, Hahn T, Chladova M, Wang XF, Zobalova R, Prochazka L, Gold M, Freeman RE, Turanek J, Akporiaye ET, Dyason J, Ralph SJ (2007b) Vitamin E analogues: a novel group of mitocans, anti-cancer agents that act by targeting mitochondria. Mol Aspects Med 28: 607-645 (Pubitemid 47625532)
30. Neuzil J, Svensson I, Weber T, Weber C, Brunk UT (1999) α-Tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation. FEBS Lett 445: 295-300 (Pubitemid 29117231)
31. Neuzil J, Tomasetti M, Mellick AS, Alleva R, Salvatore BA, Birringer M, Fariss MW (2004) Vitamin E analogues: a new class of inducers of apoptosis with selective anti-cancer effects. Curr Cancer Drug Targets 4: 355-372 (Pubitemid 38797247)
32. Neuzil J, Tomasetti M, Zhao Y, Dong LF, Birringer M, Wang XF, Low P, Wu K, Salvatore BA, Ralph SJ (2007a) Vitamin E analogs, a novel group of 'mitocans' as anticancer agents: the importance of being redox-silent. Mol Pharmacol 71: 1185-1199 (Pubitemid 46658670)
33. Neuzil J, Wang XF, Dong LF, Low P, Ralph SJ (2006) Molecular mechanism of 0mitocan0-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett 580: 5125-5129 (Pubitemid 44415781)
34. Neuzil J, Weber T, Gellert N, Weber C (2001a) Selective cancer cell killing by α-Tocopheryl succinate. Br J Cancer 84: 87-89 (Pubitemid 32102509)
35. Neuzil J, Weber T, Schröder A, Lu M, Ostermann G, Gellert N, Mayne GC, Olejnicka B, Nègre-Salvayre A, Sticha M, Coffey RJ, Weber C (2001b) Induction of apoptosis in cancer cells by α-Tocopheryl succinate: Molecular pathways and structural requirements. FASEB J 15: 403-415 (Pubitemid 32141432)
36. Neuzil J, Zhao M, Ostermann G, Sticha M, Gellert N, Weber C, Eaton JW, Brunk UT (2002) α-Tocopheryl succinate, an agent with in vivo antitumour activity, induces apoptosis by causing lysosomal instability. Biochem J 362: 709-715 (Pubitemid 34242323)
37. Ogawa M, Nakai S, Deguchi A, Nonomura T, Masaki T, Uchida N, Yoshiji H, Kuriyama S (2007) Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells. Int J Oncol 31: 323-331
38. 2, a necessary evil for cell signaling. Science 312: 1882-1883 (Pubitemid 43993698)
39. RobertsWK, Livingston PO, Agus DB, Pinilla-Ibarz J, Zelenetz A, Scheinberg DA (2002) Vaccination with CD20 peptides induces a biologically active, specific immune response in mice. Blood 99: 3748-3755 (Pubitemid 34534547)
40. Sakagami H, Satoh K (1997) Modulating factors of radical intensity and cytotoxic activity of ascorbate. Anticancer Res 17: 3513-3520 (Pubitemid 27522318)
41. Stapelberg M, Gellert N, Swettenham E, Tomasetti M, Witting PK, Procopio A, Neuzil J (2005) α-Tocopheryl succinate inhibits malignant mesothelioma by disrupting the FGF autocrine loop: the role of oxidative stress. J Biol Chem 280: 25369-25376
42. Stelling J, Sauer U, Szallasi Z, Doyle III FJ, Doyle J (2004) Robustness of cellular functions. Cell 118: 675-685 (Pubitemid 39221728)
43. Taper HS, Roberfroid M (1992) Non-toxic sensitization of cancer chemotherapy by combined vitamin C and K3 pretreatment in a mouse tumor resistant to oncovin. Anticancer Res 12: 1651-1654
44. Taper HS, Jamison JM, Gilloteaux J, Gwin CA, Gordon T, Summers JL (2001) In vivo reactivation of DNases in implanted human prostate tumors after administration of a vitamin C/K(3) combination. J Histochem Cytochem 49: 109-120 (Pubitemid 32012846)
45. Tareen B, Summers JL, Jamison JM, Neal DR, McGuire K, Gerson L, Diokno A (2008) A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy. Int J Med Sci 5: 62-67 (Pubitemid 351871013)
46. Tomasetti M, Alleva R, Borghi B, Collins AR (2001) In vivo supplementation with coenzyme Q10 enhances the recovery of human lymphocytes from oxidative DNA damage. FASEB J 15: 1425-1427
47. Tomasetti M, Rippo MR, Alleva R, Moretti S, Andera L, Neuzil J, Procopio A (2004) α-Tocopheryl succinate and TRAIL selectively synergise in apoptosis induction in human malignant mesothelioma cells. Br J Cancer 90: 1644-1653 (Pubitemid 38648251)
48. Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8: 579-591
49. Uwagawa T, Chiao PJ, Gocho T, Hirohara S, Misawa T, Yanaga K (2009) Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-κB activation. Anticancer Res 29: 3173-3178
50. Vassalle C, Boni C, Di Cecco P, Ndreu R, Zucchelli GC (2006) Automation and validation of a fast method for the assessment of in vivo oxidative stress levels. Clin Chem Lab Med 44: 1372-1375 (Pubitemid 44706719)
51. Venugopal M, Jamison JM, Gilloteaux J, Koch JA, Summers M, Giammar D, Sowick C, Summers JL (1996) Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines. Life Sci 59: 1389-1400 (Pubitemid 26344373)
52. Verrax J, Delvaux M, Beghein N, Taper H, Gallez B, Buc Calderon P (2005) Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. An in vitro comparative study. Free Radic Res 39: 649-657 (Pubitemid 40846837)
53. Wang XF, Birringer M, Dong LF, Veprek P, Low P, Swettenham E, Stantic M, Yuan LH, Zobalova R, Wu K, Ralph SJ, Ledvina M, Neuzil J (2007) A peptide adduct of vitamin E succinate targets breast cancer cells with high erbB2 expression. Cancer Res 67: 3337-3344 (Pubitemid 46724873)
54. Zahorowska B, Crowe PJ, Yang JL (2009) Combined therapies for cancer: a review of EGFR-targeted monotherapy and combination treatment with other drugs. J Cancer Res Clin Oncol 135: 1137-1148
55. Zamzami N, Marzo I, Susin SA, Brenner C, Larochette N, Marchetti P, Reed J, Kofler R, Kroemer G (1998) The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition. Oncogene 16: 1055-1063 (Pubitemid 28107943)
56. Zhu Z, Haegele AD, Thompson HJ (1997) Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis. Carcinogenesis 18: 1007-1012 (Pubitemid 28132347)